Phytochemical Name : Ailanthone

Properties Information
PhytoCAT-ID PhytoCAT-851
Phytochemical name or plant extracts Ailanthone
PMID 29552229
Literature evidence The present study revealed the presence of ailanthone-mediated antitumor effects, indicating that ailanthone may be a novel phytomedicine with potential use in breast cancer therapy.
IUPAC name (1S,4R,5R,7S,11R,13S,17S,18S,19R)-4,5,17-trihydroxy-14,18-dimethyl-6-methylidene-3,10-dioxapentacyclo[9.8.0.01,7.04,19.013,18]nonadec-14-ene-9,16-dione
Phytochemicals’ class or type of plant extracts Methanolic extract
Source of phytochemicals or plant Extracts Ailanthus altissima
Geographical availability China North-Central, China South-Central, China Southeast, Inner Mongolia, Manchuria, Taiwan, Tibet, Xinjiang
Plant parts Bark
Other cancers Breast cancer
Target gene or protein Bax, Bcl-2
Gene or Protein evidence Western blot analysis was used to detect levels of Bax and Bcl-2 protein expression, it was demonstrated that following treatment of MCF-7 cells with 0.5, 1.0, 2.0, 4.0 or 8.0 µg/ml ailanthone for 48 h, Bax expression increased, whereas that of Bcl-2 decreased markedly.
Target pathways PI3K/AKT pathway
IC50 NA
Potency The present study revealed the presence of ailanthone-mediated antitumor effects, indicating that ailanthone may be a novel phytomedicine with potential use in breast cancer therapy.
Cell line/ mice model MCF-7
Additional information  Flow cytometry assay demonstrated that ailanthone induced apoptosis and G0/G1 cell cycle arrest in MCF-7 cells. Western blotting and RT-PCR assays demonstrated that upregulation of pro-apoptotic caspase-3 and Bcl-associated X, and downregulation of anti-apoptotic apoptosis regulator B-cell lymphoma-2 in MCF-7 cells may be associated with the induction of apoptosis and inhibition of proliferation.
PubChem ID 72965
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:813521-1
Safety NA